Radionuclide Imaging in Thyroid Cancer

Chapter
Part of the Clinicians’ Guides to Radionuclide Hybrid Imaging book series (CGRHI)

Abstract

Please confirm if the author affiliation is correct.

References

  1. 1.
    Cappelli C, Castellano M, Pirola I, Gandossi E, De Martino E, Cumetti D, et al. Thyroid nodule shape suggests malignancy. Eur J Endocrinol. 2006;155:27–31.CrossRefPubMedGoogle Scholar
  2. 2.
    Ezzal S, Sarti DA, Cain DR, Braunstein GD. Thyroid incidentalomas: Prevalence by palpation and ultrasonography. Arch Intern Med. 1994;154:1338–40.Google Scholar
  3. 3.
    Brander A, Viikinkoski P, Nickels J, Kivisaari L. Thyroid gland: US screening in a random adult population. Radiology. 1995;181:683–7.CrossRefGoogle Scholar
  4. 4.
    Wienke JR, Chong WK, Fielding JR, Zou KH, Mittelstaedt CA. Sonographic features of benign thyroid nodules. J Ultrasound Med. 2003;22:1027–31.CrossRefPubMedGoogle Scholar
  5. 5.
    Hay ID, Grant CS, Van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery. 1994;112:1139–47.Google Scholar
  6. 6.
    Tourniaire J, Bernard MH, Bizzolon-Roblin MH, Bertholon-Gregoire M, Berger-Dutrieux N. 1998 Papillary microcarcinoma of the thyroid. 179 cases reported since. Presse Med. 1973;27:1467–9.Google Scholar
  7. 7.
    Papini E, Guglielmi R, Bianchini A, Crescenzi A, Taccagna S, Nardi F, et al. Risk of malignancy in nonpalpable thyroid nodules: Predictive value of ultrasound and color-doppler features. J Clin Endocrinol Metabol. 2002;87:1941–6.CrossRefGoogle Scholar
  8. 8.
    Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA. 2006;295(18):2164–7.CrossRefPubMedGoogle Scholar
  9. 9.
    Cibas ES, Ali SZ. The Bethesda System for reporting thyroid cytopathology. Thyroid. 2009;19:1159–65.CrossRefPubMedGoogle Scholar
  10. 10.
    Sarkar SD, Becker DV. Thyroid uptake and imaging. In: Becker KL, editor. Principles and practice of endocrinology and metabolism. Philadelphia: JB Lippincott; 1995. p. 307–13.Google Scholar
  11. 11.
    Shulkin BL, Shapiro B. The role of imaging tests in the diagnosis of thyroid carcinoma. Endocrinol Metab Clin North Am. 1990;19:523–41.PubMedGoogle Scholar
  12. 12.
    Charles MD. Thyroid and whole body imaging. In: Ingbar SH, Braverman LE, editors. The thyroid. 5th ed. Philadelphia: Lippincott; 1986. p. 458–78.Google Scholar
  13. 13.
    Robbins RJ, et al. The evolving role of 131I for the treatment of differentiated thyroid carcinoma. J Nucl Med. 2005;46:28S–37S.PubMedGoogle Scholar
  14. 14.
    Price DC. Radioisotopic evaluation of the thyroid and the parathyroids. Radiol Clin North Am. 1993;31:991–1015.PubMedGoogle Scholar
  15. 15.
    Kusic Z, et al. Comparison of technetium-99m and iodine-123 imaging of thyroid nodules: Correlation with pathologic findings. J Nucl Med. 1990;31:393–9.PubMedGoogle Scholar
  16. 16.
    Intenzo CM, et al. Scintigraphic manifestations of thyrotoxicosis. Radiographics. 2003;23:857–69.CrossRefPubMedGoogle Scholar
  17. 17.
    Freitas JE, Freitas AE. Thyroid and parathyroid imaging. Semin Nucl Med. 1994;24:234–45.CrossRefPubMedGoogle Scholar
  18. 18.
    Belfiore A, et al. Cancer risk in patients with cold thyroid nodules: Relevance of iodine intake, sex, age, and multinodularity. Am J Med. 1992;93:363–9.CrossRefPubMedGoogle Scholar
  19. 19.
    Van Nostrand D, et al. Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in the identification of metastasis in differentiated thyroid cancer with 131I planar whole-body imaging and 124I PET. J Nucl Med. 2012;53:359–62.CrossRefPubMedGoogle Scholar
  20. 20.
    Mazzaferri EI. Empirically treating high serum thyroglobulin levels. J Nucl Med. 2005;46:1079–88.PubMedGoogle Scholar
  21. 21.
    Spanu A, et al. 131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging. J Nucl Med. 2009;50:184–90.CrossRefPubMedGoogle Scholar
  22. 22.
    Tharp K, Israel O, Hausmann J, Bettman L, Martin WH, Daitzchman M, et al. Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma. Eur J Nucl Med Mol Imaging. 2004;31(10):1435–42.CrossRefPubMedGoogle Scholar
  23. 23.
    Delbeke D, Schoder H, Martin WH, Wahl RL. Hybrid imaging (SPECT/CT and PET/CT): improving therapeutic decisions. Semin Nucl Med. 2009;39(5):308–40.CrossRefPubMedGoogle Scholar
  24. 24.
    Filesi M, Signore A, Ventroni G, Melacrinis FF, Ronga G. Role of initial iodine-131 wholebody scan and serum thyroglobulin in differentiated thyroid carcinoma metastases. J Nucl Med. 1998;39(9):1542–6.PubMedGoogle Scholar
  25. 25.
    Lind P, Kohlfurst S. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer. Semin Nucl Med. 2006;36(3):194–205.CrossRefPubMedGoogle Scholar
  26. 26.
    Van Sorge-van Boxtel RA, van Eck-Smit BL, Goslings BM. Comparison of serum thyroglobulin, 131I and 201Tl scintigraphy in the postoperative follow-up of differentiated thyroid cancer. Nucl Med Commun. 1993;14(5):365–72.CrossRefPubMedGoogle Scholar
  27. 27.
    Wong KK, et al. Staging of differentiated thyroid carcinoma using diagnostic 131I SPECT/CT. AJR Am J Roentgenol. 2010;195:730–6.CrossRefPubMedGoogle Scholar
  28. 28.
    Schmidt D, et al. Impact of 131I SPECT/spiral CT on nodal staging of differentiated thyroid carcinoma at the first radioablation. J Nucl Med. 2009;50:18–23.CrossRefPubMedGoogle Scholar
  29. 29.
    Avram AM. Radioiodine scintigraphy with SPECT/CT: an important diagnostic tool for thyroid cancer staging and risk stratification. J Nucl Med. 2012;53:754–64.CrossRefPubMedGoogle Scholar
  30. 30.
    Maruoka Y, et al. Incremental diagnostic value of SPECT/CT with 131I scintigraphy after radioiodine therapy in patients with well-differentiated thyroid carcinoma. Radiology. 2012;265:902–9.CrossRefPubMedGoogle Scholar
  31. 31.
    Buck AK, Nekolla SG, Ziegler SI, Drzezga A. SPECT/CT. J Nucl Med. 2008;49(8):1305–19.CrossRefPubMedGoogle Scholar
  32. 32.
    American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009 Nov;19(11):1167–214.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Nuclear MedicineRoyal Liverpool University HospitalLiverpoolUK

Personalised recommendations